腺相关病毒载体在视网膜中用于CRISPR介导的体内基因组编辑
Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
作者信息
Yu Wenhan, Wu Zhijian
机构信息
Ocular Gene Therapy Core, National Eye Institute, NIH, Bethesda, MD, USA.
出版信息
Methods Mol Biol. 2019;1950:123-139. doi: 10.1007/978-1-4939-9139-6_7.
Abstract
Degenerative retinal diseases such as retinitis pigmentosa (RP) and Leber's congenital amaurosis (LCA) may lead to blindness without effective treatment. With the rapid advancement of the CRISPR/Cas9 genome editing technology, in vivo application of CRISPR/Cas9 holds immense potential for treatment of these diseases. Adeno-associated virus (AAV) vectors are an ideal gene transfer tool for delivery of CRISPR components to the retina. Here, we describe a protocol for utilizing an AAV-based CRISPR/Cas9 system for in vivo genome editing in the retina.
摘要
诸如色素性视网膜炎（RP）和莱伯先天性黑矇（LCA）等退行性视网膜疾病若没有有效的治疗方法，可能会导致失明。随着CRISPR/Cas9基因组编辑技术的迅速发展，CRISPR/Cas9在体内的应用为治疗这些疾病具有巨大潜力。腺相关病毒（AAV）载体是将CRISPR组件递送至视网膜的理想基因传递工具。在此，我们描述了一种利用基于AAV的CRISPR/Cas9系统在视网膜中进行体内基因组编辑的方案。
相似文献
1
Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.腺相关病毒载体在视网膜中用于CRISPR介导的体内基因组编辑
Methods Mol Biol. 2019;1950:123-139. doi: 10.1007/978-1-4939-9139-6_7.
2
Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.成年小鼠视网膜体内CRISPR/Cas编辑方法
Methods Mol Biol. 2018;1715:113-133. doi: 10.1007/978-1-4939-7522-8_9.
3
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.AAV-CRISPR 基因编辑被 Cas9 预先存在的免疫所否定。
Mol Ther. 2020 Jun 3;28(6):1432-1441. doi: 10.1016/j.ymthe.2020.04.017. Epub 2020 Apr 19.
4
Somatic Gene Editing of by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque.通过 AAV-CRISPR/Cas9 对 的体细胞基因编辑改变了小鼠和猕猴的视网膜结构和功能。
Hum Gene Ther. 2019 May;30(5):571-589. doi: 10.1089/hum.2018.193. Epub 2018 Dec 20.
5
AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.体内视网膜细胞的腺相关病毒介导的CRISPR/Cas基因编辑
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3470-6. doi: 10.1167/iovs.16-19316.
6
CRISPR Systems Suitable for Single AAV Vector Delivery.适用于单一腺相关病毒载体递送的CRISPR系统。
Curr Gene Ther. 2022;22(1):1-14. doi: 10.2174/1566523221666211006120355.
7
Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.AAV-CRISPR 载体中的启动子定向影响 Cas9 表达和基因编辑效率。
CRISPR J. 2020 Aug;3(4):276-283. doi: 10.1089/crispr.2020.0021.
8
CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.基于 CRISPR 的基因组编辑作为视网膜疾病的一种新治疗工具。
Mol Biotechnol. 2021 Sep;63(9):768-779. doi: 10.1007/s12033-021-00345-4. Epub 2021 May 31.
9
In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.通过 AAV-CRISPR-Cas9 介导的靶向基因调控的原位基因治疗。
Mol Ther. 2018 Jul 5;26(7):1818-1827. doi: 10.1016/j.ymthe.2018.04.017. Epub 2018 Apr 25.
10
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.通过自互补 AAV 递送系统增强 CRISPR-Cas9 对杜氏肌营养不良症小鼠的校正。
Sci Adv. 2020 Feb 19;6(8):eaay6812. doi: 10.1126/sciadv.aay6812. eCollection 2020 Feb.
引用本文的文献
1
CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review.CRISPR/Cas9介导的胶质母细胞瘤基因治疗：一项范围综述
Biomedicines. 2024 Jan 21;12(1):238. doi: 10.3390/biomedicines12010238.
2
Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems.纳米载体：CRISPR/Cas系统递送的新策略
Front Chem. 2022 Jul 26;10:957572. doi: 10.3389/fchem.2022.957572. eCollection 2022.
3
Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications.用于潜在临床应用的成簇规律间隔短回文重复序列/CRISPR相关技术的发展
World J Clin Cases. 2022 Jun 26;10(18):5934-5945. doi: 10.12998/wjcc.v10.i18.5934.
4
Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells.AAV 递送的基于 CRISPR/Cas9 的 HPV18-E6 基因降解对 HeLa 细胞的抗增殖作用。
Sci Rep. 2022 Feb 9;12(1):2224. doi: 10.1038/s41598-022-06025-w.
5
Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus.腺相关病毒递送超紧凑型 Cas12f1 和工程化向导 RNA 实现高效 CRISPR 编辑。
Nat Biotechnol. 2022 Jan;40(1):94-102. doi: 10.1038/s41587-021-01009-z. Epub 2021 Sep 2.
6
Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing.使用CRISPR/Cas9基因编辑在体内恢复RPGR表达。
Gene Ther. 2022 Feb;29(1-2):81-93. doi: 10.1038/s41434-021-00258-6. Epub 2021 Jul 14.
7
Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters.由肝脏特异性启动子表达的AAV8衍生的CRISPR/SaCas9对乙型肝炎病毒的抑制作用
Front Microbiol. 2021 Jun 26;12:665184. doi: 10.3389/fmicb.2021.665184. eCollection 2021.
本文引用的文献
1
Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.针对视紫红质相关显性视网膜色素变性的单碱基P23H突变进行等位基因特异性CRISPR-Cas9基因组编辑
CRISPR J. 2018 Feb;1(1):55-64. doi: 10.1089/crispr.2017.0009.
2
genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.使用AAV-CRISPR系统对动物进行基因组编辑：在人类疾病转化研究中的应用
F1000Res. 2017 Dec 20;6:2153. doi: 10.12688/f1000research.11243.1. eCollection 2017.
3
Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.Cas9/sgRNA 对 P23H 视蛋白突变等位基因的靶向选择，通过玻璃体内 AAV9.PHP.B 载体递送来治疗色素性视网膜炎。
Hum Mol Genet. 2018 Mar 1;27(5):761-779. doi: 10.1093/hmg/ddx438.
4
In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells.通过慢病毒递送CRISPR/Cas9在小鼠视网膜色素上皮细胞中对Vegfa基因进行体内敲除
Mol Ther Nucleic Acids. 2017 Dec 15;9:89-99. doi: 10.1016/j.omtn.2017.08.016. Epub 2017 Sep 21.
5
Genome editing abrogates angiogenesis in vivo.基因组编辑在体内消除血管生成。
Nat Commun. 2017 Jul 24;8(1):112. doi: 10.1038/s41467-017-00140-3.
6
Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.AAV 递送的 CRISPR/Cas9 基因敲除可预防小鼠视网膜变性。
Nat Commun. 2017 Mar 14;8:14716. doi: 10.1038/ncomms14716.
7
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni.利用源自空肠弯曲菌的小 Cas9 直系同源物进行体内基因组编辑。
Nat Commun. 2017 Feb 21;8:14500. doi: 10.1038/ncomms14500.
8
Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.使用Cas9核糖核蛋白进行基因组手术治疗年龄相关性黄斑变性。
Genome Res. 2017 Mar;27(3):419-426. doi: 10.1101/gr.219089.116. Epub 2017 Feb 16.
9
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10.CRISPR/Cas9介导的基因组编辑作为治疗莱伯先天性黑蒙10型的一种方法
Mol Ther. 2017 Feb 1;25(2):331-341. doi: 10.1016/j.ymthe.2016.12.006. Epub 2017 Jan 18.
10
In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.通过在小鼠视网膜中电穿孔基于质粒的CRISPR/Cas9对人突变视紫红质基因进行体内编辑。
Mol Ther Nucleic Acids. 2016 Nov 22;5(11):e389. doi: 10.1038/mtna.2016.92.
Zotero 插件